Only in the past decade has intraocular lens (IOL) implantation become widely recognized as a safe and effective procedure. It can justifiably be considered one of the most important innovations in ophthalmology in this century. New lens designs, improved manufacturing techniques, and quality controls plus advanced microsurgical techniques have all contributed to this success.
Throughout the history of IOLs, much of the original work, both theoretical and applied, has been carried out by ophthalmologists in private practice working in concert with industry. Despite early recommendations,1 federal granting agencies have provided surprisingly little support. With few exceptions, governmental and university-based institutions have played a disproportionately small role in promoting the evolution of lens design and implantation procedures.
ECONOMICS AND DISSEMINATION OF INFORMATION
In addition to the primary goal of providing good patient care, other considerations have unfortunately often dominated the practice of IOL implantation. Recent hearings conducted by Congressman Claude
Apple DJ. Intraocular Lenses: Notes From an Interested Observer. Arch Ophthalmol. 1986;104(8):1150–1152. doi:10.1001/archopht.1986.01050200056048
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: